Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

VHT Guru Trades in

VHT Guru Trades in

Q4 2015

VHT Guru Trades in Q4 2015

Ken Fisher 1,808 sh (New)
» More
Q1 2016

VHT Guru Trades in Q1 2016

Ken Fisher Sold Out
» More

Ratios

vs
industry
vs
history
P/E(ttm) 22.30
VHT's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 22.30 )
Ranked among companies with meaningful P/E(ttm) only.
VHT' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 22.9
Current: 22.3
0
22.9
PE(NRI) 22.30
VHT's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 22.30 )
Ranked among companies with meaningful PE(NRI) only.
VHT' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 22.9
Current: 22.3
0
22.9
P/B 3.47
VHT's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 3.47 )
Ranked among companies with meaningful P/B only.
VHT' s P/B Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 3.61
Current: 3.47
0
3.61

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.13
VHT's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 2.13 )
Ranked among companies with meaningful Dividend Yield only.
VHT' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 2.13
Current: 2.13
0
2.13
Yield on cost (5-Year) 2.13
VHT's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 2.13 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
VHT' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 2.13
Current: 2.13
0
2.13

More Statistics

Short Percentage of Float0.00%
52-Week Range $114.49 - 143.58
Shares Outstanding(Mil)44600000.00
» More Articles for VHT

Headlines

Articles On GuruFocus.com
U.S. Market Indexes Close Lower for the Week Apr 29 2016 
Carl Icahn Interview With CNBC Apr 29 2016 
Mattel Is a Definite Short Right Now Apr 29 2016 
Here Are PayPal’s Growth Drivers for the Next Decade Apr 29 2016 
Why Icahn Sold Apple Apr 29 2016 
Apple Is Facing a Big Problem Apr 29 2016 
Gap May Be Poised for a Comeback Apr 29 2016 
3 Stocks Warren Buffett Should Buy Apr 29 2016 
Rainwater, Banks and REITs Apr 29 2016 
This Sportswear Company Is Poised to Grow Apr 29 2016 

More From Other Websites
Johnson & Johnson’s 1Q16 Valuation Cheat Sheet Apr 29 2016
What Developments Did Merck & Co. See during 1Q16? Apr 28 2016
UnitedHealth Solid Q1 Earnings Put These ETFs in Focus Apr 21 2016
Healthcare ETFs to Buy on Blockbuster J&J Q1 Results Apr 20 2016
ETF Flows: Health Care ETFs Are Shedding Assets in 2016 (FXH, XLV) Apr 19 2016
2016 Investment Landscape: Right Sector at the Right Time Apr 19 2016
Existing Chemotherapy Drugs for Lymphoma Apr 07 2016
Will 2016 See Continued Healthcare Mergers and Acquisitions? Apr 07 2016
The Zacks Analyst Blog Highlights: Allergan, Pfizer, Health Care Select Sector SPDR Fund, iShares... Apr 07 2016
Business Cycle Perspective: Has the Healthcare Sector Hit Bottom? Mar 31 2016
Biotech Stocks Offer a Greater Risk-to-Reward Trade-Off Mar 31 2016
What Analysts Are Recommending Now for Baxter International Mar 21 2016
VHT Vs. XLV: Comparing Health Care ETFs Mar 09 2016
The Zacks Analyst Blog Highlights: SPDR S&P Health Care Services ETF, Health Care Select Sector SPDR... Mar 09 2016
Trump Healthcare Reforms: Will ETFs Gain Health or Suffer? Mar 08 2016
Drug Patent Expirations: $190 Billion Is Up for Grabs Mar 03 2016
Will Generic Drugs Help Curb Healthcare Costs? Mar 02 2016
Key Products Drove Pfizer’s Growth in 4Q15 Feb 16 2016
Aetna’s Commercial Enrollments Declined by 0.11 Million in 4Q15 Feb 16 2016
Pfizer’s Loss of Product Exclusivity Affected Its 4Q15 Revenues Feb 09 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK